Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 281

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Staging Cardiac Damage in Patients With Asymptomatic Aortic Valve Stenosis

Open access
Tastet, Lionel, Tribouilloy, Christophe, Maréchaux, Sylvestre, Vollema, E. Mara, Delgado, Victoria, Salaun, Erwan, Shen, Mylène, Capoulade, Romain, Clavel, Marie-Annick, Arsenault, Marie, Bédard, Élisabeth, Bernier, Mathieu, Beaudoin, Jonathan, Narula, Jagat, Lancellotti, Patrizio, Bax, Jeroen J., Généreux, Philippe, Pibarot, Philippe·2019·Journal of the American College of Cardiology

Abstract

BACKGROUND The optimal timing of intervention in patients with asymptomatic severe aortic stenosis (AS) remains controversial. OBJECTIVES This multicenter study sought to test and validate the prognostic value of the staging of cardiac damage in patients with asymptomatic moderate to severe AS. METHODS This study retrospectively analyzed the clinical, Doppler echocardiographic, and outcome data that were prospectively collected in 735 asymptomatic patients (71 ± 14 years of age; 60% men) with at least moderate AS (aortic valve area <1.5 cm2) and preserved left ventricular ejection fraction (≥50%) followed in the heart valve clinics of 4 high-volume centers. Patients were classified according to the following staging classification: no cardiac damage associated with the valve stenosis (Stage 0), left ventricular damage (Stage 1), left atrial or mitral valve damage (Stage 2), pulmonary vasculature or tricuspid valve damage (Stage 3), or right ventricular damage or subclinical heart failure (Stage 4). The primary endpoint was all-cause mortality. RESULTS At baseline, 89 (12%) patients were classified in Stage 0, 200 (27%) in Stage 1, 341 (46%) in Stage 2, and 105 (14%) in Stage 3 or 4. Median follow-up was 2.6 years (interquartile range: 1.1 to 5.2 years). There was a stepwise increase in mortality rates according to staging: 13% in Stage 0, 25% in Stage 1, 44% in Stage 2, and 58% in Stages 3 to 4 (p < 0.0001). The staging was significantly associated with excess mortality in multivariable analysis adjusted for aortic valve replacement as a time-dependent variable (hazard ratio: 1.31 per each increase in stage; 95% CI: 1.06 to 1.61; p = 0.01), and showed incremental value to several clinical variables (net reclassification index = 0.34; p = 0.003). CONCLUSIONS The new staging system characterizing the extra-aortic valve cardiac damage provides incremental prognostic value in patients with asymptomatic moderate to severe AS. This staging classification may be helpful to identify asymptomatic AS patients who may benefit from elective aortic valve replacement.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2019.04.065

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 281

Metadata

Authors
Tastet, L., Tribouilloy, C., Maréchaux, S., Vollema, E. M., Delgado, V., Salaun, E., Shen, M., Capoulade, R., Clavel, M.-A., Arsenault, M., Bédard, É., Bernier, M., Beaudoin, J., Narula, J., Lancellotti, P., Bax, J. J., Généreux, P., & Pibarot, P.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2019-07
Volume
74
Issue
4
Pages
550-563
ISSN
0735-1097 (ISSN-L)
OpenAlex
W4205537664
Cited by
281
References
30
FWCI
17.61
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Staging Cardiac Damage in Patients With Asymptomatic Aortic Valve Stenosis. https://app.cochat.ai/papers/10.1016/j.jacc.2019.04.065
The paper
Tastet, L., Tribouilloy, C., Maréchaux, S., Vollema, E. M., Delgado, V., Salaun, E., Shen, M., Capoulade, R., Clavel, M.-A., Arsenault, M., Bédard, É., Bernier, M., Beaudoin, J., Narula, J., Lancellotti, P., Bax, J. J., Généreux, P., & Pibarot, P. (2019). Staging Cardiac Damage in Patients With Asymptomatic Aortic Valve Stenosis. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2019.04.065

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.